Study Details
Testing the Study Drug Solrikitug for Adults with Eosinophilic Esophagitis
(IRB#: IRB_00182390)
Eosinophilic Esophagitis (EoE) is when the esophagus (which connects the throat to the stomach) becomes inflamed, causing heartburn and swelling and making it hard to swallow. This study will test a study drug called Solrikitug to treat adults with EoE. The study wants to see if Solrikitug will help people with the disease and is safe. People in this study will be randomly chosen to be treated with Solrikitug or a placebo. A placebo looks like the study drug but does not have the study medicine. Being in the study requires attending up to 20 visits at the study clinic for about 72 weeks. Medical tests will be done during the study to track the health of participants.
- All genders
- Over 18 years old
- Volunteers with special conditions
- In Person
- Paid
Who can participate?
Gender: All genders
Age: Over 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria
- Ages 18 to 75 years old
- Diagnosis of EoE before participation
- History of weekly dysphagia (difficulty swallowing) at least 4 weeks before participation
- Childbearing age must use specific birth control
- Attend in-person visits at the study clinic
Exclusion Criteria
- History or presence of any other disease of the gastrointestinal tract such as Crohns disease, Celiac disease, or cancer
- Untreated gastroesophageal (stomach and esophagus) reflux (stomach acid or bile irritates the food pipe lining) disease
- Have known serious infections
- History of bleeding disorders
- Pregnant or breastfeeding
Will I be paid for my time?
Yes
IRB#: IRB_00182390
PI: Kathryn Peterson
Department: INTERNAL MEDICINE
Approval Date: 2025-01-08 07:00:00
Specialties: Gastroenterology
I am Interested